We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Study Could Weaken Merck's Vioxx Defense: Report

Law360 (July 3, 2007, 12:00 AM EDT) -- A new study which reportedly lends credibility to evidence that Merck & Co.'s Vioxx increased the risk of heart attacks in patients immediately after they started taking the drug could drive...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.